Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Pharmaxis Ltd ( (AU:SNT) ) just unveiled an announcement.
Pharmaxis Ltd has released a shareholder update for the March quarter, focusing on its subsidiary, Syntara. The update includes forward-looking statements about Syntara’s future financial position and the potential of its products. However, it cautions that actual results may differ due to various risks and uncertainties, and there is no guarantee of success in developing or partnering products in their pipeline.
More about Pharmaxis Ltd
YTD Price Performance: -38.75%
Average Trading Volume: 3,589,326
Technical Sentiment Signal: Buy
Current Market Cap: A$79.58M
Find detailed analytics on SNT stock on TipRanks’ Stock Analysis page.